3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
4
Neoplasms
4
Prostatic Neoplasms
3
Glioma
3
Glioblastoma
3
Uterine Cervical Dysplasia
2
Sarcoma
2
Breast Neoplasms
2
Atypical Squamous Cells of the Cervix
2
Astrocytoma
2
Xeroderma Pigmentosum
1
Triple Negative Breast Neoplasms
1
Trichothiodystrophy Syndromes
1
Squamous Intraepithelial Lesions
1
Spinal Cord Neoplasms
1
Sexuality
1
Pilonidal Sinus
1
Peritoneal Neoplasms
1
Pelvic Organ Prolapse
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neurofibroma
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Meningioma
1
Melanoma
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leiomyoma
1
Interventions
Cyclophosphamide
12
Specimen Handling
9
cabozantinib
8
X-Rays
8
Magnetic Resonance Spectroscopy
8
fludarabine
7
Phantoms, Imaging
7
Biopsy
7
Temozolomide
6
Gemcitabine
5
regorafenib
4
pembrolizumab
4
Vincristine
4
Nuclear Medicine Department, Hospital
4
Nivolumab
4
Methotrexate
4
Doxorubicin
4
olaparib
3
irinotecan sucrosofate
3
fludarabine phosphate
3
dinutuximab
3
Zoledronic Acid
3
Surveys and Questionnaires
3
Irinotecan
3
Ifosfamide
3
Cisplatin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Restraint, Physical
×
1 year
×
Clear all
No trials found.